和铂医药-B(02142.HK) 披露业务进展及更新,预期截至2024年12月31日止年度,将录得溢利介乎730万元至2,200万元人民币。另外,公司的现金溢利(经营现金净流入)达到2.2亿元人民币的历史新高。过往派息公布日期派息事项派息内容2024/08/28中期业绩无派息2024/03/28末期业绩无派息2023/08/28中期业绩无派息2023/03/29末期业绩无派息和铂医药解释,其可持续...
Source Link和铂医药-B(02142.HK) 披露业务进展及更新,预期截至2024年12月31日止年度,将录得溢利介乎730万元至2,200万元人民币。另外,公司的现金溢利(经营现金净流入)达到2.2亿元人民币的历史新高。过往派息公布日期派息事项派息内容2024/08/28中期业绩无派息2024/03/28末期业绩无派息2023/08/28中期业绩无派息2023/03/29末期业绩无派息和铂医药解释,其可持续...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.